3.8 Article

Blood Biomarkers in Brain Injury Medicine

Related references

Note: Only part of the references are listed.
Editorial Material Pharmacology & Pharmacy

Blood-Based Alzheimer's Biomarkers

[Anonymous]

CLINICAL PHARMACOLOGY & THERAPEUTICS (2022)

Review Neurosciences

Neurochemical Markers of Traumatic Brain Injury: Relevance to Acute Diagnostics, Disease Monitoring, and Neuropsychiatric Outcome Prediction

Pashtun Shahim et al.

Summary: Considerable advancements have been made in the quantification of biofluid-based biomarkers for traumatic brain injury (TBI), providing a clinically accessible window for investigating disease mechanisms and progression. However, most of the research has focused on acute TBI diagnostics, with relatively little literature on biomarkers for long-term sequelae.

BIOLOGICAL PSYCHIATRY (2022)

Review Clinical Neurology

Blood-based biomarkers for Alzheimer's disease: towards clinical implementation

Charlotte E. Teunissen et al.

Summary: Recent research suggests that blood-based biomarkers for Alzheimer's disease may become a reality, with consistent results across different cohorts. Additionally, other blood-based biomarkers can provide information about disease progression and treatment effects.

LANCET NEUROLOGY (2022)

Review Critical Care Medicine

Blood-Based Protein Biomarkers for the Management of Traumatic Brain Injuries in Adults Presenting to Emergency Departments with Mild Brain Injury: A Living Systematic Review and Meta-Analysis

Stefania Mondello et al.

Summary: The study found that measurement of S100B can help informed decision making in the emergency department, but there is insufficient evidence that any of the other markers is ready for clinical application. Serious problems in the design, analysis, and reporting of many of the studies were identified, as well as substantial heterogeneity and research gaps.

JOURNAL OF NEUROTRAUMA (2021)

Article Critical Care Medicine

Interleukin-8 Predicts Fatigue at 12 Months Post-Injury in Children with Traumatic Brain Injury

Alison Crichton et al.

Summary: This study aimed to determine whether persisting fatigue in children with traumatic brain injury could be predicted by serum biomarker concentrations, particularly IL-8. The results showed that IL-8 was the best serum biomarker for estimating the likelihood of children experiencing fatigue at 12 months post-injury, and significantly improved predictive models of fatigue based on severity.

JOURNAL OF NEUROTRAUMA (2021)

Article Medical Laboratory Technology

Utility of serum macrophage migration inhibitory factor as a potential biomarker for detection of cerebrocardiac syndrome following severe traumatic brain injury

Jun-Xia Dai et al.

Summary: This study found that serum MIF concentration was significantly higher in patients with severe traumatic brain injury compared to healthy controls, and was closely correlated with Glasgow coma scale scores and C-reactive protein concentration. Serum MIF concentration may be a useful biomarker for early detection of posttraumatic cerebrocardiac syndrome.

CLINICA CHIMICA ACTA (2021)

Article Critical Care Medicine

High-Sensitivity C-Reactive Protein Is a Prognostic Biomarker of Six-Month Disability after Traumatic Brain Injury: Results from the TRACK-TBI Study

Linda B. Xu et al.

Summary: The study found that hsCRP levels in TBI patients and orthopedic trauma controls rose between days 1 and 5, then fell within 2 weeks but remained higher compared to healthy controls. Within the first two weeks, hsCRP was significantly higher in patients with death/severe disability compared to those with moderate disability/good recovery, with the highest AUC at 2 weeks.

JOURNAL OF NEUROTRAUMA (2021)

Article Pathology

Blood-based traumatic brain injury biomarkers - Clinical utilities and regulatory pathways in the United States, Europe and Canada

Kevin K. Wang et al.

Summary: Traumatic brain injury (TBI) is a major global health issue, and biomarkers aid in the diagnosis and pathophysiological characterization of TBI. Major consortium multicenter observational studies have been created in the USA, Europe, and Canada, with the formation of the International Initiative for Traumatic Brain Injury Research (InTBIR) to facilitate data integration and dissemination.

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2021)

Review Critical Care Medicine

Biofluid Biomarkers in Traumatic Brain Injury: A Systematic Scoping Review

Maryam Edalatfar et al.

Summary: This study conducted a systematic scoping review of evidence on biofluid-based biochemical markers of traumatic brain injuries (TBI), extracting 540 biomarkers from 1036 studies across 19 distinct categories. Cytokines, coagulation tests, and nerve tissue proteins were the most commonly investigated biomarker categories, with cortisol being the most frequently measured biomarker across blood, cerebrospinal fluid, urine, and saliva. The studies primarily focused on adult populations with severe and blunt injuries.

NEUROCRITICAL CARE (2021)

Article Clinical Neurology

Head injury and 25-year risk of dementia

Andrea L. C. Schneider et al.

Summary: The study showed a dose-dependent relationship between head injury and dementia risk, with stronger associations among female and White participants.

ALZHEIMERS & DEMENTIA (2021)

Article Behavioral Sciences

The biological significance and clinical utility of emerging blood biomarkers for traumatic brain injury

Megan E. Huibregtse et al.

Summary: Blood biomarkers can provide objective measures in traumatic brain injury (TBI) assessment and predict recovery duration. Proteomic markers, often examined in research, have short half-lives due to degradation, while emerging biomarkers like microRNA and extracellular vesicles can better reflect the genetic and metabolic alterations following TBI.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2021)

Article Multidisciplinary Sciences

Extracellular vesicle concentrations of glial fibrillary acidic protein and neurofilament light measured 1 year after traumatic brain injury

Spencer Flynn et al.

Summary: The study found that blood-derived EV concentrations of GFAP and NfL are higher in TBI patients compared to controls even 1 year after injury, and are related to injury severity and poor recovery outcomes, suggesting that TBIs alter the activity of these biomarkers, likely contributing to individual variability in recovery.

SCIENTIFIC REPORTS (2021)

Article Emergency Medicine

Accuracy of a rapid glial fibrillary acidic protein/ubiquitin carboxyl-terminal hydrolase L1 test for the prediction of intracranial injuries on head computed tomography after mild traumatic brain injury

Jeffrey J. Bazarian et al.

Summary: The rapid i-STAT-based test showed high sensitivity for predicting acute TII, comparable to lab-based platforms. The speed, portability, and high accuracy of this test may facilitate clinical adoption of brain biomarker testing as an aid to head CT decision making in EDs.

ACADEMIC EMERGENCY MEDICINE (2021)

Review Clinical Neurology

The Clinical Use of Serum Biomarkers in Traumatic Brain Injury: A Systematic Review Stratified by Injury Severity

Nadeem Al-Adli et al.

Summary: This systematic review provides a comprehensive overview of the diagnostic and prognostic utility of blood-based biomarkers in traumatic brain injury (TBI). The study found that these biomarkers correlate with different severity levels of TBI and concussion cases, offering valuable clinical insights for diagnostic and prognostic evaluations.

WORLD NEUROSURGERY (2021)

Article Medical Laboratory Technology

Plasma Protein Profiling by Proximity Extension Assay Technology Reveals Novel Biomarkers of Traumatic Brain Injury-A Pilot Study

Michelle Chen et al.

Summary: Utilizing high-throughput proximity extension assays, researchers identified 6 novel candidate biomarkers for TBI, showing significant increase in plasma protein abundance in severe TBI patients. These biomarkers have potential clinical utility in aiding TBI diagnosis, prognosis, and management.

JOURNAL OF APPLIED LABORATORY MEDICINE (2021)

Article Clinical Neurology

The Diagnostic Competence of Glial Fibrillary Acidic Protein in Mild Traumatic Brain Injury and Its Prognostic Value in Patient Recovery

Arash Forouzan et al.

Summary: In a study of 176 patients with brain trauma, it was found that 79.5% had no complications or symptoms three months after the injury. The AUC for GFAP was 72.6%, showing good accuracy in predicting the need for neurosurgical intervention. Therefore, GFAP may be a useful predictive factor for identifying individuals with mild TBI who may require neurosurgery.

TURKISH NEUROSURGERY (2021)

Article Clinical Neurology

Blood Biomarkers Relate to Cognitive Performance Years after Traumatic Brain Injury in Service Members and Veterans

Sara M. Lippa et al.

Summary: This study found that serum UCH-L1 and GFAP may predict cognitive outcomes following complicated mild and more severe TBI, with unexpected correlations in the injured control group.

JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY (2021)

Article Neurosciences

Elevated serum and urine levels of progranulin (PGRN) as a predictor of microglia activation in the early phase of traumatic brain injury: a further link with the development of neurodegenerative diseases

Mieszko Olczak et al.

Summary: TBI is a common finding in forensic autopsies, and there is a need to improve its diagnosis through novel biomarkers like the neurotrophic and anti-inflammatory factor PGRN. This study observed elevated levels of PGRN in biofluids and increased expression in brain tissue of TBI individuals, indicating a potential new tool for TBI diagnosis and research. The use of biofluid assays may also aid in clinical prognosis and risk assessment for non-fatal TBI cases.

FOLIA NEUROPATHOLOGICA (2021)

Article Biochemistry & Molecular Biology

miR-142-3p Expression Is Predictive for Severe Traumatic Brain Injury (TBI) in Trauma Patients

Cora Rebecca Schindler et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Clinical Neurology

Neurofilament light as a biomarker in traumatic brain injury

Pashtun Shahim et al.

NEUROLOGY (2020)

Article Multidisciplinary Sciences

Large-scale informatic analysis to algorithmically identify blood biomarkers of neurological damage

Grant C. O'Connell et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Article Clinical Neurology

Changes in Plasma von Willebrand Factor and Cellular Fibronectin in MRI-Defined Traumatic Microvascular Injury

Danielle K. Sandsmark et al.

FRONTIERS IN NEUROLOGY (2019)

Review Emergency Medicine

Serum cardiac troponins as prognostic markers in patients with traumatic and non-traumatic brain injuries: A meta-analysis

Ayman El-Menyar et al.

AMERICAN JOURNAL OF EMERGENCY MEDICINE (2019)

Review Neurosciences

A Review of MicroRNA Biomarkers in Traumatic Brain Injury

Hamna Atif et al.

JOURNAL OF EXPERIMENTAL NEUROSCIENCE (2019)

Article Medical Laboratory Technology

Clinical validation of S100B in the management of a mild traumatic brain injury: issues from an interventional cohort of 1449 adult patients

Gautier Allouchery et al.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2018)

Review Pathology

The Glymphatic System in Central Nervous System Health and Disease: Past, Present, and Future

Benjamin A. Plog et al.

ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 13 (2018)

Review Behavioral Sciences

Blood biomarkers in paediatric mild traumatic brain injury: a systematic review

Micaela Lugones et al.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2018)

Review Medicine, General & Internal

Traumatic Brain Injury and Alzheimer's Disease: The Cerebrovascular Link

Jaime Ramos-Cejudo et al.

EBIOMEDICINE (2018)

Review Neurosciences

The role of brain vasculature in neurodegenerative disorders

Melanie D. Sweeney et al.

NATURE NEUROSCIENCE (2018)

Article Sport Sciences

Response of protein S100B to playing American football, lifting weights, and treadmill running

Matthew J. Rogatzki et al.

SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS (2018)

Review Neurosciences

The diagnostic values of UCH-L1 in traumatic brain injury: A meta-analysis

Shima Shahjouei et al.

BRAIN INJURY (2018)

Article Critical Care Medicine

Serum Neurofilament Light Protein as a Marker for Diffuse Axonal Injury: Results from a Case Series Study

Johan Ljungqvist et al.

JOURNAL OF NEUROTRAUMA (2017)

Article Clinical Neurology

Acute plasma tau relates to prolonged return to play after concussion

Jessica Gill et al.

NEUROLOGY (2017)

Review Neurosciences

MSCs-Derived Exosomes and Neuroinflammation, Neurogenesis and Therapy of Traumatic Brain Injury

Yongxiang Yang et al.

FRONTIERS IN CELLULAR NEUROSCIENCE (2017)

Review Behavioral Sciences

Blood biomarkers for brain injury: What are we measuring?

Keisuke Kawata et al.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2016)

Article Clinical Neurology

Blood Biomarkers for Brain Injury in Concussed Professional Ice Hockey Players

Pashtun Shahim et al.

JAMA NEUROLOGY (2014)

Review Neurosciences

Axonal pathology in traumatic brain injury

Victoria E. Johnson et al.

EXPERIMENTAL NEUROLOGY (2013)

Review Clinical Neurology

Chronic neuropathologies of single and repetitive TBI: substrates of dementia?

Douglas H. Smith et al.

NATURE REVIEWS NEUROLOGY (2013)

Review Neurosciences

Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders

Berislav V. Zlokovic

NATURE REVIEWS NEUROSCIENCE (2011)

Article Critical Care Medicine

Juguloarterial Endothelin-1 Gradients After Severe Traumatic Brain Injury

Doris A. Chatfield et al.

NEUROCRITICAL CARE (2011)

Article Medical Laboratory Technology

Neurobiochemical Markers of Brain Damage in Cerebrospinal Fluid of Acute Ischemic Stroke Patients

Raf Brouns et al.

CLINICAL CHEMISTRY (2010)

Article Neurosciences

Endothelin-1 is Elevated in Alzheimer's Disease Brain Microvessels and is Neuroprotective

Jinhua Luo et al.

JOURNAL OF ALZHEIMERS DISEASE (2010)

Article Critical Care Medicine

Human Traumatic Brain Injury Alters Plasma microRNA Levels

John B. Redell et al.

JOURNAL OF NEUROTRAUMA (2010)

Review Clinical Neurology

Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury

Dan Shlosberg et al.

NATURE REVIEWS NEUROLOGY (2010)

Article Medical Laboratory Technology

Reference ranges for neuroprotein S-100B: from infants to adolescents

Christoph Castellani et al.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2008)

Article Clinical Neurology

High serum S100B levels for trauma patients without head injuries

RE Anderson et al.

NEUROSURGERY (2001)

Article Clinical Neurology

Fibroblasts can express glial fibrillary acidic protein (GFAP) in vivo

JA Hainfellner et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2001)